The potential of Sofosbuvir in opposition to COVID-19 neurological signs

On eleventh March 2020, the World Well being Group (WHO) introduced the worldwide unfold of the extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) because the coronavirus illness 2019 (COVID-19). 

Regardless of the invention of efficient COVID-19 vaccines and the next graduation of vaccination packages globally, SARS-CoV-2 infections have been extensively reported as a result of emergence of recent variants that may escape immune responses induced by way of each vaccination and pure an infection. Thus, there stays a substantial want for novel, quick-deployable, and environment friendly antiviral therapies.

Research: SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir. Picture Credit score: Gorodenkoff /


Along with respiratory misery, COVID-19 sufferers additionally expertise adversarial direct or oblique impacts on the central nervous system (CNS). A number of neurological signs, equivalent to stroke, epilepsy, anosmia, ageusia, hallucinations, and encephalopathy, have been related to SARS-CoV-2 an infection. 

One mouse mannequin revealed that the SARS-CoV-2 spike S1 protein can cross the blood-brain barrier, thereby indicating that the virus can infect the mind and induce neurological signs. Post-mortem experiences of sufferers who died from COVID-19 confirmed the presence of SARS-CoV-2 in cortical neurons. Moreover, the potential of vertical transmission of SARS-CoV-2 to the fetus has been discovered, which may have an effect on fetal mind growth. 

Human mind organoids are three-dimensional fashions of the mind that mimic mobile and molecular elements of human embryonic and fetal developmental levels. Earlier research revealed that human mind cortical practical organoids can carefully recapitulate the early levels of neural growth and set up cortical networks. 

Concerning the examine

In a latest PLoS Biology examine, researchers talk about how SARS-CoV-2 infects cortical neurons and damages their synapses that type the connection between mind cells. This piece of analysis not solely evaluates the chance of SARS-CoV-2 an infection in human mind cells but in addition analyzes its affect on the creating human mind.

The TISSUES database helped establish proteins related to SARS-CoV-2 an infection within the human mind. Among the proteins expressed within the mind embody transmembrane serine protease 2 (TMPRSS2), angiotensin-converting enzyme 2 (ACE2), neuropilin-1 (NRP1), and CD147, however not CD26.

These entry issue proteins are expressed at a decreased stage within the CNS as in comparison with different organs. ACE2 and TMPRSS2, for instance, are much less expressed in comparison with NRP1, which is extremely expressed within the cerebral cortex and hippocampus. Nevertheless, BSG/CD147 gene is extremely expressed in all mind areas.  

To check whether or not SARS-CoV-2 may infect the creating human mind, researchers created eight-week-old human mind cortical organoids (BCO) utilizing dermal fibroblasts from wholesome donors. Organoids had been contaminated with SARS-CoV-2 to find out whether or not BCOs had been susceptible to SARS-CoV-2 an infection.

One of many essential elements of this analysis was to establish United States Meals and Drug Administration(FDA)-approved antiviral medication that may alleviate neurological signs attributable to SARS-CoV-2 an infection. On this examine, BCO contaminated with the influenza A virus, utilizing the identical experimental design, was used as management.

Research findings

Sofosbuvir (SOF) is an antiviral drug that has acquired approval from the FDA for hepatitis C (HCV) therapy. Notably, this drug may inhibit different single-stranded viruses, together with coronaviruses. Because of this, the present examine assessed the efficacy of SOF in assuaging neurological manifestations in COVID-19 sufferers.

Mechanistically, SOF inhibits HCV replication by proscribing the exercise of the ribonucleic acid (RNA)-dependent RNA polymerase (RdRp). A excessive diploma of sequence and structural similarity was discovered between the RdRp of SARS-CoV-2 and HCV.

Importantly, SOF-binding residues are conserved amongst a number of coronaviruses, together with SARS-CoV-2. Contemplating these observations, the authors hypothesized that SOF may successfully inhibit SARS-CoV-2 replication.

A various vary of SOF dosages was used for BOC therapy. To this finish, an elevated dose of SOF was discovered to successfully lower intracellular SARS-CoV-2 RNA ranges.

However, the best inhibition of SARS-CoV-2 replication, with out inducing cell dying, occurred at 20 μM SOF focus. Moreover, the efficacy of SOF was validated by analyzing intracellular viral RNA and the variety of viable viruses current within the supernatants of SARS-CoV-2-infected BCOs handled with SOF. 

Importantly, a decreased variety of infectious viruses had been detected after antiviral therapy. Immunoblotting and immunostaining experiments additional validated the aforementioned findings.

Due to this fact, experimental findings underscored the efficacy of SOF in combating COVID-19. Notably, SOF therapy not solely decreased SARS-CoV-2 viral protein ranges but in addition decreased virus-induced cell dying.

Nestin+ NPCs and MAP2+ neurons had been discovered to be inclined to SARS-CoV-2 an infection. An elevated stage of nucleocapsid protein of SARS-CoV-2 in BCO was linked with elevated cell dying in each neurons and neural progenitor cells (NPC).

To evaluate the affect of COVID-19 on synaptic integrity, the variety of excitatory synapses in neurons was quantified utilizing Synapsin 1, vGLUT1, and PSD95 antibodies. A big lower in pre-synaptic proteins was noticed throughout SARS-CoV-2 an infection, which was successfully alleviated utilizing SOF therapy.


Though experimental findings demonstrated the effectiveness of SOF in enhancing the neurological circumstances of COVID-19 sufferers, extra medical evaluations are wanted for additional validation. However, SOF seems to be a promising drug for stopping the event of neurological signs in COVID-19 sufferers.

Journal reference:



Leave a Reply